BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Drug Discovery in the era of large-scale genetics and genomics dat
 a - Philippe Sanseau (Glaxo SmithKline)
DTSTART:20220209T140000Z
DTEND:20220209T150000Z
UID:TALK163324@talks.cam.ac.uk
CONTACT:Samantha Noel
DESCRIPTION:Drug discovery remains a very long and costly process with red
 ucing attrition a major objective. We have shown previously that using hum
 an genetics evidence may increase the chance of success in the clinic for 
 drug targets. In addition\, functional genomics technologies that can meas
 ure or perturb the genome at scale can also be used to identify and valida
 te new drug targets\, support patient stratification or understanding of m
 echanism of action. In this talk\, using examples. I will describe how the
  combination of large scale genetics and functional genomics data combined
  with analytics is impacting drug discovery.
LOCATION:CMS\, Meeting Room 15
END:VEVENT
END:VCALENDAR
